Stay updated on Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the site content. This appears to be a metadata/version-control change rather than a modification to the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-27T05:54:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page’s documentation or formatting rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-05T12:37:36.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, indicating a small publication/backend update without changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-28T06:17:35.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study page now indicates that enrollment is closed with a 'No longer looking for participants' note, and new help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention/Treatment header formatting was adjusted and the revision version updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:06:31.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5. This reflects an update to the site's revision tracking rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-07T01:16:03.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page now displays a new revision tag: Revision: v3.5.4. The previous revision tag Revision: v3.5.3 has been removed.
    Difference
    0.1%
    Check dated 2026-05-16T09:28:47.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.